姜黄素对七氟醚吸入后老年大鼠认知功能的影响

中国临床药理学与治疗学 ›› 2014, Vol. 19 ›› Issue (6): 638-643.

姜黄素对七氟醚吸入后老年大鼠认知功能的影响

左蕾, 刘丹彦, 李琪英

重庆医科大学附属第一医院麻醉科, 重庆 400016

收稿日期:2013-11-25 修回日期:2014-06-04 发布日期:2014-07-01
通讯作者: 刘丹彦, 女, 主任医师, 研究方向:脑保护围术期炎症反应。E-mail: liudanyan418@qq.com
作者简介:左蕾, 女, 硕士, 医师, 研究方向:认知功能障碍与麻醉。Tel: 023-89012152 E-mail: machiatto0@qq.com
基金资助:
重庆市卫生局科学技术研究项目(20102076);重庆市医学重点学科[渝卫科教〔2007〕2号];卫生部国家临床重点专科[财社〔2011〕170号]

Curcumin mitigates the changes of cognitive function by sevoflurane anesthesia in aged rats

ZUO Lei, LIU Dan-yan, LI Qi-ying

Department of Anesthesiology, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China

Received:2013-11-25 Revised:2014-06-04 Published:2014-07-01

摘要/Abstract

摘要： 目的: 观察姜黄素对七氟醚所致老年大鼠学习记忆力改变的影响以及对环氧合酶-2(COX-2)表达的影响。方法: 将48只18月龄的SD老年大鼠, 采用数字表法随机分为3组。分别为姜黄素组(n=16);七氟醚对照组(n=16);空白对照组(n=16)。采用Morris水迷宫检测大鼠的空间学习记忆功能, 以及检测COX-2、β淀粉样蛋白(β-amyloid peptide, Aβ)以及人β-分泌酶(human beta-site APP-cleaving enzyme-1, BACE-1)的表达。结果: (1) Morris水迷宫进行定位航行实验和空间探索实验表明, 七氟醚组及姜黄素组的老年SD大鼠学习记忆与空白对照组相比, 平均逃避潜伏期延长, 穿越平台象限的次数减少(P<0.05), 七氟醚组较姜黄素组平均逃避潜伏期及穿越平台象限的次数显著减少(P<0.05);(2)大鼠海马区Aβ的表达: 七氟醚组明显高于姜黄素组及空白对照组(P<0.05), 而姜黄素组较空白对照组亦有明显差异(P<0.05);(3)七氟醚组、姜黄素组BACE-1的表达明显高于空白对照组(P<0.05);(4)七氟醚组、姜黄素组大鼠海马区COX-2的表达较空白对照组无显著差异(P>0.05)。结论: 姜黄素有助于改善高浓度七氟醚所致老年SD大鼠学习记忆力损害, 其机制可能与下调BACE-1表达从而抑制高浓度七氟醚诱导Aβ的生成有关, 但对COX-2表达无显著影响。

关键词: 姜黄素, 七氟醚, 认知功能, 水迷宫, COX-2

Abstract: AIM : To investigate the curcumin effect on cognitive function after sevoflurane anesthesia with high concentration and the expression of Cyclooxygenase-2 in aged rats.METHODS: Forty-six male Sprague Dawley SD rats aged 18 months weighing 490-590 g were randomyly divided into three groups: Blank control group (n=16), sevoflurane group (n=16), 3% sevoflurane and curcumin group (curcumine group, n=16) ; sevoflurane group and curcumine group received anesthesia for 6 h. The cognitive function was tested with Morris Watermaze. Aβ, COX-2 and BACE-1 expressions in the hippocampus were determined with enzyme-linked immunosorbent assays and Western-Blot.RESULTS:Compared with the control group, both latency and the number of seeking for hidden-platform has significant difference in sevoflurane and curcumine groups (P<0.05), there were significant differences between the sevoflurane group and curcumine group(P<0.05).Compared with blank control group, the expression of Aβ in the hippocampus had significant differences in curcumine group (P<0.05), but no significant differences between the blank control and curcumine groups(P>0.05).Compared with the blank control group, the expression of BACE-1 in hippocampal was significant increased in sevoflurane and curcumine groups (P<0.05).There were no significant differences among the sevoflurane group, curcumine group and blank control group(P<0.05).CONCLUSION: Curcumin might mitigate cognitive function impairment induced by sevoflurane with high concentration.Possibly by suppress APP, Aβ generation and caused down-regulation of BACE-1.

Key words: curcumin , sevoflurane , cognitive function, Morris watermaze, COX-2

左蕾, 刘丹彦, 李琪英. 姜黄素对七氟醚吸入后老年大鼠认知功能的影响[J]. 中国临床药理学与治疗学, 2014, 19(6): 638-643.

ZUO Lei, LIU Dan-yan, LI Qi-ying. Curcumin mitigates the changes of cognitive function by sevoflurane anesthesia in aged rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 638-643.

参考文献

[1] Hu NI, Guo D.Involvement of the blood-brain barrier opening in cognitive decline in aged rats following orthopedic surgery and high concentration of sevoflurane inhalation[J].Brain Res, 2014 Mar 10;1551:13-24. doi: 10.1016/j.brainres.2014.01.015. Epub 2014 Jan 16.
[2] Mythri RB, Bharath MM. Curcumin; a potential neuroprotective agent in Parkinson's disease[J]. Curr Pharm Des, 2012, 18(1):91-99.
[3] 李金纯, 韦红, 贾盛华, 等.姜黄素对新生鼠坏死性小肠结肠炎模型的抗氧化作用及机制[J].中国临床药理学与治疗学, 2013, 18 (1): 17-20.
[4] Brondino NI, Re SI.Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies[J]. Sci World J, 2014 Jan 22;2014:174282. eCollection 2014.
[5] Thiyagarajan M, Sharama SS. Neeurorprotective effect of curcumin in middle cerebral arteryocclusion induced focal cerebral ischemia in rats[J]. Life Sci, 2004, 74:969-985.
[6] 中华临床医师杂志(电子版)2011年10 月第5卷第19 期　China Clinicians (Electronic Edition), October 1, 2011, Vol.5, NO.19.
[7] Vassar R. Beta-secretase. APP and abeta in alzheimer's disease [J]. Subcell Biochem, 2005, 38:79-103.
[8] 王蓬文, 李瑞晟, 王虹, 等.姜黄素对APPswe/PS1dE9 双转基因小鼠Aβ生成和降解的影响[J].中国实验动物学报, 2010, 18 (5) :367-371.
[9] Shimmyo Y, Kihara T, Akaike A, et al. Epigallo-catechin-3-gallate and curcumin suppress amyloid beta-in-duced beta-site APP cleaving enzyme-1upregulation[J]. Neuroreport , 2008, 19:1329-1333.
[10]Yang F, Lim GP, Begum AN, et al.Curcumin inhibits formation of amy-loid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo[J].J Biol Chem, 2005;280:5892-5901.
[11]Ono K, Hasegawa K, Naiki H, et al. Curcumin has potent anti-amyloid ogenic effects for Alzheimer's beta-amyloid fibrils in vitro [J]. Neurosci Res 2004, 3 (15) :742-750.
[12]Yanagisawa D, Shirai N, Amatsubo T, et al. Relation-ship between the tautomeric structures of curcumin deriva-tives and their Ab-binding activities in the context of therapies for Alzheimer's disease [J]. Biomaterials , 2010, 31(14):4179-4185.
[13]Terrando N, Monaco C, Ma D, Foxwell BM, et al. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline[J]. Proc Natl Acad Sci USA , 2010, 107: 20518-20522.
[14]Reksidler AB, Lima MM, Zanata SM, et al. The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTPlesioned rats[J]. Eur J Pharmacol, 200, 560(2/3): 163-175.
[15]Heindl B, Reichle F.Sevoflurane but isoflurane can reduce prostacyclin production of endothelial cells[J].Eur J Anaesthesiol, 2003, 20(2):116-119.
[16]Liu R, Luo J, Li J, et al. Protective mechanisms of sevoflurane against one-lung ventilation-induced acute lung injury:role of cyclooxygenase-2 and 5-lipoxgenase pathways[J].J South Med Univ, 2013, 33(5):625-630.
[17]Yang H, Chen C. Cyclooxygenase-2 in synaptic signaling[J].Curr in Pharm Des, 2008, 14(14): 1443-1451.
[18]Liang X, Wu L, Wang Q, et al. Function of COX-2 and prostaglandins in Neurological disease[J]. J Mol Neurosci , 2007, 33(1): 94-99.
[19]Cole GM, M Orihara T, Lim GP, et al. NSAID, and Antioxidant Prevention of Alzheimer's disease: lessons from in vitro and Animal models [J] Ann NY Acad Sci, 2004, 1035:68-84.